Christian Haass @dzne.science berichtet von den heute verfügbaren Antikörpertherapien #Lecanemab / #Leqembi, #Donanemab / #Kisunla und #Aducunumab / #Aduhelm, die von Beginn an mithilfe von #Tierversuche n entwickelt wurden, und wie neue Technologien die Forschung seines Teams heute verändern.
ICER on #Aduhelm for #Alzheimers - "Independent appraisal committee unanimously determined the evidence is not adequate to demonstrate that aducanumab provides a net health benefit."
Conclusion: its use violates evidence-based...
NEW in @STATnews with @StephenLatham @YaleBioethics:
Patient advocacy organizations and FDA drug approval: lessons from Aduhelm
#Aduhelm #aducanumab #patientadvocacy #patientadvocate #patientsoverprofits
The vacuum of institutional leadership on #Aduhelm has been lifted.
Thank you, @ClevelandClinic and @MountSinaiNYC for choosing evidence-based medicine by not prescribing aducanumab to patients.
www.nytimes.com/2021/07/14/health/clevel...
